Cargando…

Nintedanib Treatment After Ovulation is an Effective Therapeutic Strategy for the Alleviation of Ovarian Hyperstimulation Syndrome (OHSS) in a Mouse Model

PURPOSE: Ovarian hyperstimulation syndrome (OHSS) is a serious complication of controlled ovarian hyperstimulation. In this study, we hope to explore whether nintedanib, a tyrosine kinase inhibitor, can inhibit OHSS by blocking signaling of vascular endothelial growth factor in a mouse model. Consid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Shutian, Li, Wenzhi, Zhao, Xinxi, Chen, Li, Kuang, Yanping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865761/ https://www.ncbi.nlm.nih.gov/pubmed/35221672 http://dx.doi.org/10.2147/DDDT.S351292

Ejemplares similares

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter
por: Abuzeid, M., et al.
Publicado: (2014)

Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)
por: Farkas, Balint, et al.
Publicado: (2020)

Melatonin Ameliorates Ovarian Hyperstimulation Syndrome (OHSS) through SESN2 Regulated Antiapoptosis
por: Zheng, Min, et al.
Publicado: (2023)

Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2015)

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021)

Erratum to: Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2016)

Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)—a retrospective case–control study
por: Nouri, Kazem, et al.
Publicado: (2014)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

The Use of High Dose Letrozole in Ovulation Induction and Controlled Ovarian Hyperstimulation
por: Pritts, Elizabeth A., et al.
Publicado: (2011)

Ovarian Hyperstimulation Syndrome (OHSS) requiring Intensive Care Unit (ICU) admission between 1996-2020 in England, Wales, and Northern Ireland
por: Abbara, Ali, et al.
Publicado: (2022)

The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome
por: Chappell, Neil, et al.
Publicado: (2017)

Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy
por: Abbara, Ali, et al.
Publicado: (2015)

The pregnancy outcomes of infertile women with polycystic ovary syndrome undergoing intrauterine insemination with different attempts of previous ovulation induction
por: Gao, Yining, et al.
Publicado: (2022)

Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E(2) Synthesis and Inhibiting Thrombospondin-1 (TSP-1)
por: Zhai, Junyu, et al.
Publicado: (2017)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

The Effect of Spontaneous LH Surges on Pregnancy Outcomes in Patients Undergoing Letrozole-HMG IUI: A Retrospective Analysis of 6,285 Cycles
por: Jiang, Shutian, et al.
Publicado: (2022)

Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic
por: Banker, Manish, et al.
Publicado: (2015)

Expression of tissue factor and tissue factor pathway inhibitors during ovulation in rats: a relevance to the ovarian hyperstimulation syndrome
por: Jang, You Jee, et al.
Publicado: (2021)

OHSS Free Clinic
por: Devroey, P., et al.
Publicado: (2011)

The impact of blastomere loss on pregnancy and neonatal outcomes of vitrified-warmed Day3 embryos in single embryo transfer cycles
por: Jiang, Shutian, et al.
Publicado: (2022)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

New algorithm for OHSS prevention
por: Papanikolaou, Evangelos G, et al.
Publicado: (2011)

Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction
por: Ghahiri, Ataollah, et al.
Publicado: (2015)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2017)

Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax
por: Ma, Xiaowei, et al.
Publicado: (2023)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization
por: Jiang, Shutian, et al.
Publicado: (2017)

Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor
por: Tahermanesh, Kobra, et al.
Publicado: (2022)

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
por: Huang, Jianfang, et al.
Publicado: (2022)

Severe ovarian hyperstimulation syndrome leading to ICU admission
por: Singh, R. K., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gl0tj64vimu1414sv00q092859